
Exactus, Inc. 
 Share · US30066P2011    (OTC)
                    No Price
                
            n/a
        
        Company Profile for Exactus, Inc. Share
    
 Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.
 Company Data
Name Exactus, Inc.
 Company Exactus, Inc.
  Website 
                            http://www.exactushemp.com
                        
 Primary Exchange 
                        UTC
                    
  ISIN US30066P2011
 Asset Class Share
     Sector Healthcare
 Industry Drug Manufacturers - Specialty & Generic
 CEO Alvaro Daniel Alberttis
  Country United States of America
 Currency USD
 Employees -
 Address 80 NE 4th Avenue,  Delray Beach
 IPO Date 2015-12-30
Ticker Symbols
| Name | Symbol | 
|---|---|
| Over The Counter | EXDI | 
            More Shares
            
 
                Investors who hold Exactus, Inc. also have the following shares in their portfolio:
            
            The financial platform MoneyPeak tracks and analyzes investments and portfolios.
 From securities portfolios to crypto purchases.
            
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
 Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



